Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Devane

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Therapeutic Drug Monitoring|January 1, 1985
Stability of bupropion and its major metabolites in human plasmaS C Laizure, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Journal of Clinical Psychopharmacology|June 1, 1999
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentrationJ S Markowitz, C L DeVane
Chirality|September 14, 2000
Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadoneD W Boulton, C L Devane
The Journal of Clinical Psychiatry|October 8, 1999
Pharmacokinetic considerations of antidepressant use in the elderlyC L DeVane, B G Pollock
Clinical Pharmacokinetics|August 21, 2001
Clinical pharmacokinetics of quetiapine: an atypical antipsychoticC L DeVane, C B Nemeroff
Journal of Chromatography|October 4, 1991
Determination of cocaine, benzoylecgonine and ecgonine methyl ester in plasma by reversed-phase high-performance liquid chromatographyR L Miller, C L DeVane
Archives of General Psychiatry|March 1, 1984
Differences in diazepam and oxazepamC L DeVane, R B Stewart
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Therapeutic Drug Monitoring|January 1, 1985
Stability of bupropion and its major metabolites in human plasmaS C Laizure, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Journal of Clinical Psychopharmacology|June 1, 1999
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentrationJ S Markowitz, C L DeVane
Chirality|September 14, 2000
Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadoneD W Boulton, C L Devane
The Journal of Clinical Psychiatry|October 8, 1999
Pharmacokinetic considerations of antidepressant use in the elderlyC L DeVane, B G Pollock
Clinical Pharmacokinetics|August 21, 2001
Clinical pharmacokinetics of quetiapine: an atypical antipsychoticC L DeVane, C B Nemeroff
Journal of Chromatography|October 4, 1991
Determination of cocaine, benzoylecgonine and ecgonine methyl ester in plasma by reversed-phase high-performance liquid chromatographyR L Miller, C L DeVane
Archives of General Psychiatry|March 1, 1984
Differences in diazepam and oxazepamC L DeVane, R B Stewart
Pageof 13